Transcriptomic Analysis of Histone Methyltransferase Setd7 Knockdown and Phenethyl Isothiocyanate in Human Prostate...

Area of Science:

• Molecular Biology
• Cancer Research
• Epigenetics

Background:

• Prostate cancer (PCa) remains a significant health concern.
• Understanding the molecular mechanisms underlying PCa is crucial for developing effective treatments.
• The role of the epigenetic modifier Setd7 and the effects of phenethyl isothiocyanate (PEITC) in PCa are not fully elucidated.

Purpose of the Study:

• To perform transcriptomic analysis of Setd7 knockdown (KD) in human prostate cancer (PCa) LNCaP cells.
• To evaluate the effects of phenethyl isothiocyanate (PEITC) on gene expression in PCa LNCaP cells.
• To identify potential molecular targets and signaling pathways affected by Setd7 KD and PEITC.

Main Methods:

• Microarray analysis of RNA from wild-type and Setd7-KD LNCaP cells.
• Treatment of cells with and without PEITC.
• Ingenuity® Pathway Analysis (IPA) for differential gene expression profiling.

Main Results:

• Setd7 KD significantly impacted a broader range of genes with higher fold changes compared to PEITC treatment.
• Both Setd7 KD and PEITC altered critical signaling pathways, including inflammation-related TNFR signaling and PTEN/PI3K/AKT signaling.
• A subset of genes was commonly affected by both PEITC and Setd7 KD, suggesting potential synergistic molecular targets.

Conclusions:

• This research provides novel insights into the mechanisms of Setd7 and PEITC in PCa cells.
• The findings enhance the understanding of isothiocyanate compounds, like PEITC, as potential agents for PCa prevention and treatment.
• Identifying shared molecular targets offers new avenues for therapeutic strategies in prostate cancer.